Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

N3785

Sigma-Aldrich

Nabilone

solid, ≥98% (HPLC)

Synonym(s):

LY-109514

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C24H36O3
CAS Number:
51022-71-0
Molecular Weight:
372.54
MDL number:
MFCD00941490
UNSPSC Code:
12352200
PubChem Substance ID:
329818640
NACRES:
NA.77
Pricing and availability is not currently available.

Quality Level

100

Assay

≥98% (HPLC)

form

solid

drug control

USDEA Schedule II; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

color

white

solubility

DMSO: soluble ~18 mg/mL
H2O: insoluble

application(s)

forensics and toxicology
veterinary

shipped in

wet ice

storage temp.

2-8°C

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
MABS519ABS552SAB56000289
Anti-P40 (TP63) Antibody, clone 11H1 clone 11H1, from mouse

MABT1497

Anti-P40 (TP63) Antibody, clone 11H1

Anti-P40 Antibody, clone 11F12.1 clone 11F12.1, from mouse

MABS519

Anti-P40 Antibody, clone 11F12.1

Anti-p40 Antibody from rabbit, purified by affinity chromatography

ABS552

Anti-p40 Antibody

Anti-p63 (Tumor Protein 63) Rabbit Monoclonal Antibody clone RM383, affinity purified immunoglobulin

SAB56000289

Anti-p63 (Tumor Protein 63) Rabbit Monoclonal Antibody

species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

biological source

mouse

biological source

mouse

biological source

rabbit

biological source

-

clone

11H1, monoclonal

clone

11F12.1, monoclonal

clone

polyclonal

clone

RM383, monoclonal

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

affinity isolated antibody

antibody form

affinity purified immunoglobulin

isotype

IgG1κ

isotype

IgG2aκ

isotype

-

isotype

IgG

Biochem/physiol Actions

CB1 and CB2 cannabinoid receptor agonist.

Features and Benefits

This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Pictograms

Health hazardExclamation mark
GHS08,GHS07

Signal Word

Warning

Hazard Statements

H302,H336,H361

Hazard Classifications

Acute Tox. 4 Oral - Repr. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    071M4604V
    087K4623
    063K4619

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Adrienne Curtis et al.
    Movement disorders : official journal of the Movement Disorder Society, 24(15), 2254-2259 (2009-10-22)
    Pilot study of nabilone in Huntington's disease (HD). Double-blind, placebo-controlled, cross-over study of nabilone versus placebo. Primary outcome, Unified Huntington's Disease Rating Scale (UHDRS) total motor score. Secondary measures: UHDRS subsections for chorea, cognition and behavior, and neuropsychiatric inventory (NPI).
    Mark A Ware et al.
    Addiction (Abingdon, England), 105(3), 494-503 (2010-04-21)
    Nabilone is a synthetic cannabinoid prescription drug approved in Canada since 1981 to treat chemotherapy-induced nausea and vomiting. In recent years, off-label use of nabilone for chronic pain management has increased, and physicians have begun to express concerns about nabilone
    Nabilone in inflammatory pain: to be or not to be.
    Josée Guindon
    Clinical and experimental pharmacology & physiology, 39(4), 327-328 (2012-03-28)
    Barbara Todaro
    Journal of the National Comprehensive Cancer Network : JNCCN, 10(4), 487-492 (2012-04-12)
    Before the introduction of the serotonin receptor antagonists (5-HT3 receptor antagonists) in the early 1990s, limited effective options were available to prevent and treat chemotherapy-induced nausea and vomiting (CINV). In 1985, the FDA approved 2 cannabinoid derivatives, dronabinol and nabilone
    Cannabinoids in the treatment of symptoms in cancer and AIDS, 2nd edition #93.
    L Scott Wilner et al.
    Journal of palliative medicine, 14(4), 509-510 (2011-04-08)
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service